⌘K
Loading ticker…
GSK plc American Depositary Shares (Each representing two Ordinary Shares) · Healthcare · Pharmaceutical Products
As of 2026-06-26, GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) has a 3-month relative strength percentile of 35 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 53. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 1.7%, relative volume 1.05×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
35 is not yet a leadership-grade RS read, Market Stance is 47
Daily range, ATR, beta, and the math for a 1-ADR stop.
GSK is in a stage 3 topping pattern, week 1. Currently in a 89-day base; basing ADR 1.7% (broad 1.4%). VCP detected: no. RS line below base-start high. Distance from 50d / 200d: 1.0% / 4.2%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
GSK appears in 1 ETF as of Mar 2026: FVD at 0.44% weight, $36M notional.
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| FVDFirst Trust Value Line Dividend Index Fund | 0.44% | $36M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GSK Jan avg: 4.07% median: 4.75% win: 100% σ: 2.63% n: 4 2022-04-12 → 2026-05-29 | GSK Feb avg: 6.15% median: 6.41% win: 75% σ: 7.11% n: 4 2022-04-12 → 2026-05-29 | GSK Mar avg: 0.63% median: 2.69% win: 75% σ: 4.90% n: 4 2022-04-12 → 2026-05-29 | GSK Apr avg: -1.40% median: -2.58% win: 40% σ: 3.36% n: 5 2022-04-12 → 2026-05-29 | GSK May avg: -0.44% median: -3.05% win: 40% σ: 5.89% n: 5 2022-04-12 → 2026-05-29 | GSK Jun avg: -3.80% median: -3.63% win: 25% σ: 8.51% n: 4 2022-04-12 → 2026-05-29 (current) | GSK Jul avg: -6.31% median: -1.73% win: 25% σ: 10.92% n: 4 2022-04-12 → 2026-05-29 | GSK Aug avg: -1.04% median: 2.77% win: 50% σ: 15.78% n: 4 2022-04-12 → 2026-05-29 | GSK Sep avg: -1.08% median: -1.86% win: 50% σ: 8.54% n: 4 2022-04-12 → 2026-05-29 | GSK Oct avg: 2.42% median: 3.53% win: 50% σ: 10.25% n: 4 2022-04-12 → 2026-05-29 | GSK Nov avg: 0.02% median: 1.47% win: 75% σ: 4.99% n: 4 2022-04-12 → 2026-05-29 | GSK Dec avg: 1.53% median: 2.03% win: 75% σ: 1.72% n: 4 2022-04-12 → 2026-05-29 |